Perspective Therapeutics, Inc.CATXNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P57
Within normal range
vs 5Y Ago
-11.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-12.65%
2024125.55%
2023-169.67%
2022-105.41%
2021-115.04%
20201.12%
201934.14%
201821.56%
2017-6.69%
2016-24.10%